Skip to the main content.
Contact Us

At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

News & Events

Posts about

News (2)

GLYCOCALYX RESEARCH ACCELERATES WITH THE BIOFLUX SYSTEM

Glycocalyx research utilizing the BioFlux System

RECENT PUBLICATIONS VALIDATE FLUXION'S LIQUID BIOPSY TECHNOLOGIES

Publications demonstrate depth and breadth of Fluxion’s liquid biopsy technologies

FLUXION BIOSCIENCES RECEIVES NATIONAL CANCER INSTITUTE GRANT FOR DEVELOPMENT OF ERASE-SEQ LIQUID BIOPSY TECHNOLOGY

Grant will support advanced development and clinical validation with researchers at Cleveland Clinic

FLUXION BIOSCIENCES LAUNCHES CUSTOM LIQUID BIOPSY NGS PANEL DEVELOPMENT

Custom panels can be now be validated and analyzed using ERASE-Seq variant caller

FLUXION INTRODUCES NEW PLATE FORMAT FOR TESTING CUSTOM SUBSTRATES

New plate format allows users to test bacterial growth on a variety of substrates

Fluxion launches BioFlux DCIS integrated digital microscopy solution

Digital Cell Imaging System for live cell analysis under shear flow

Fluxion Launches New Dual Gas Option for BioFlux Controllers

New controller option allows control of 2 independent gas inputs for developing gas concentration...

Fluxion Biosciences Launches New BioFlux Plate for Studying Catheter Infections

New plate format utilizes silicone rubber construction to allow detailed study of indwelling...

NEW DATA DEMONSTRATES SUPERIOR ACCURACY OF FLUXION’S ERASE-SEQ VARIANT CALLER FOR LIQUID BIOPSIES

Inter-sample digital processing improves sensitivity and specificity of variant calling; results...

FLUXION BIOSCIENCES ANNOUNCES LAUNCH OF ERASE-SEQ NGS LIQUID BIOPSY ANALYSIS SERVICE

Cloud-based ERASE-Seq delivers ultra-high sensitivity somatic mutation detection using background...